Delivery Order SPE2DB24D1205-SPE2DB25FCVSC
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.41 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a performance period ending on March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,724.31, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. This is a firm fixed-price delivery order contract with a period of performance through March 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.54 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.00, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. This contract is...
This federal contract award, valued at $1,674.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $1,061.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of August 1, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,759.12, is for the supply of NAYZILAM 5 MG NASAL SPRAYS to support federal government healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 27, 2024. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $1,043.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, and has an ultimate completion date of April 18, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NAYZILAM 5 MG NASAL SPRAYS to the U.S. government. The contract, valued at $1,344.52, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,540.06 firm fixed-price delivery order is for the supply of 4,567,925,570 units of the drug NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...